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38 Abstract 
 
 
39 Background/Objectives: Cardiovascular disorders are recognised as important modifiable 
 
40 risk factors for falls. However the association between falls and orthostatic hypotension (OH) 
 
41 remains ambivalent, particularly because of poor measurement methods of previous studies. 
 
42 Our goal was to determine for the first time to what extent OH (and variants) are risk factors 
 
43 for incident falls, unexplained falls (UF), injurious falls (IF) and syncope using dynamic blood 
 
44 pressure (BP) measurements in a population study. 
 
 
45 Design: Nationally Representative Longitudinal Cohort Study - The Irish Longitudinal Study 
 
46 on Ageing (TILDA) – wave 1 (2009-2011) with 2 year follow-up at wave 2 (2012-2013). 
 
 
47 Setting: Community dwelling adults. 
 
 
48 Participants: 4127 participants were randomly sampled from the population of older adults 
 
49 aged ≥50 years resident in Ireland. 
 
 
50 Measurements: Continuous BP recordings measured during active stands were analysed. 
 
51 OH and variants (initial OH and impaired orthostatic BP stabilisation OH(40)) were defined 
 
52 using dynamic BP measurements. Associations with the number of falls, UF, IF and syncope 
 
53 reported two years later were assessed using negative binomial and modified Poisson 
 
54 regression. 
 
 
55 Results: Participants had a mean age 61.5(8.2) years (54.2% female). OH(40) was associated 
 
56 with increased relative risk of UF (RR:1.52 95%CI:1.03-2.26). OH was associated with all- 
 
57 cause falls (IRR:1.40 95%CI:1.01-1.96), UF(RR:1.81 95%CI:1.06-3.09), and IF(RR:1.58 
 
58 95%CI:1.12-2.24). IOH was not associated with any outcome. 
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59 Conclusion: With the exception of initial orthostatic hypotension, beat-to-beat measures of 
 
60 impaired orthostatic BP recovery (delayed or incomplete stabilisation) are independent risk 
 
61 factors for future falls, unexplained falls, and injurious falls. 
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77 INTRODUCTION 
 
 
78 Falls are the leading cause of injury in older people (1,2). One in three people over the age 
 
79 of 65 will suffer a fall each year (3) with healthcare costs associated with falls rising (4). With 
 
80 40% of falls preventable, evidence for causative, treatable factors is essential (5). 
 
 
81 Cardiovascular disorders are among several risk factors which have been identified to cause 
 
82 falls; in particular unexplained falls (UF) (defined as those for which no attributable 
 
83 mechanical cause such as a trip or slip can be found) and recurrent falls (6). Syncope 
 
84 secondary to underlying cardiovascular disease is more common with advancing years and 
 
85 may lead to injurious falls (IF) (7,8). 
 
 
86 In a recent systematic review from our group (9), whereas a strong association between 
 
87 many cardiovascular disorders (10) and falls was reported the association between falls and 
 
88 OH was ambivalent. This was attributed to varied quality of reviewed studies which 
 
89 employed several different assessment methods to detect OH, inadequate details to enable 
 
90 adjustment for relevant confounders and sample populations which varied in size, most of 
 
91 which were convenience samples. In addition, recent findings from the TILDA study (11) 
 
92 note a high prevalence of OH variants among older adults, as defined using continuous beat- 
 
93 to-beat BP measurements. The clinical relevance of these findings are unknown (12). 
 
94 Furthermore no previous cohort studies have examined the association between OH and UF 
 
95 where the associations might be greatest (9,13,14). 
 
 
96 This paper provides an opportunity to redress these shortcomings by presenting continuous 
 
97 orthostatic BP measurements in a randomly selected community population of well 
 
98 characterised cognitively normal adults, followed longitudinally to capture details of falls, 
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99 injurious events and syncope. Here we test the hypothesis that failure of orthostatic BP to 
 
100 stabilise after standing is associated with incident all-cause falls and more specifically UF, IF 
 
101 and syncope in older adults. 
 
 
102 METHODS 
 
 
103 Setting and Participants 
 
 
104 Analysis was performed on data obtained from wave 1(Sept 2009-July 2011) and wave 
 
105 2(April 2012-July 2013) of The Irish Longitudinal Study on Ageing(TILDA), a nationally 
 
106 representative longitudinal cohort study of adults aged 50 and over resident in the Republic 
 
107 of Ireland. Ethical approval was obtained for the study from Trinity College Research Ethics 
 
108 committee and written informed consent was obtained prior to participation. The cohort 
 
109 was recruited based on the RANSAM sampling framework with a wave 1 household 
 
110 response rate of 62% (15). 
 
 
111 Assessments 
 
 
112 The TILDA study design has been described previously (16, 17). Briefly, data collection at 
 
113 wave 1 involved a computer-assisted personal interview(CAPI) carried out in the 
 
114 respondents’ homes that included questions on socioeconomic and health circumstances, a 
 
115 self-completion questionnaire, and a research nurse led health assessment in a study centre. 
 
116 The second interview took place approximately 2 years after the first and included a 
 
117 detailed falls and syncope history. 
 
 
118 Inclusion and Exclusion Criteria 
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119 Every member of the population of Ireland aged 50 and over living in the community 
 
120 (excluding long-term care or other institutions) was equally likely to be invited to participate. 
 
121 All participants who had orthostatic BP measured at wave 1 of the study were eligible for 
 
122 inclusion. Participants with moderate to severe cognitive difficulties (because of likelihood 
 
123 of poor recall and therefore inaccuracy of falls and syncope details), those who had been 
 
124 institutionalized between waves or whose falls data was missing or was provided by a proxy 
 
125 at wave 2were excluded. 
 
 
126 Outcome Variables Measured during Wave 2 
 
 
127 At wave 2, participants were asked: i) Have you fallen since your last interview?; (ii) How 
 
128 many times have you fallen since your last interview?; (iii) Were any of these falls non- 
 
129 accidental, i.e. with no apparent or obvious reason? (unexplained falls, UF); (iv) Did you 
 
130 injure yourself seriously enough to need medical treatment? (injurious falls, IF). Questions (i) 
 
131 and (ii) were repeated for syncope. Note those with prior syncope were asked a modified 
 
132 version of question ii) How many times have you fainted or blacked out in the last year? 
 
133 Four outcome variables were derived for longitudinal analyses in keeping with our 
 
134 hypotheses: number of falls (0-5+), any UF (binary variable), any IF (binary variable), any 
 
135 reported faint (binary variable). 
 
 
136 Baseline Predictor Variables Measured during Wave 1 
 
 
137 Orthostatic BP Measurement 
 
 
138 BP responses to orthostasis were measured at wave 1 (16). In brief continuous BP responses 
 
139 were recorded using a calibrated volume clamp method (Finometer®, Finapres Medical 
 
140 Systems BV, Amsterdam, The Netherlands). Participants rested in the supine position for 10 
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141 minutes and when requested stood quickly and remained standing for 2 minutes. Beat-to- 
 
142 beat systolic BP(SBP), diastolic BP(DBP) was monitored throughout . Subjects were then 
 
143 asked to report postural symptoms i.e. dizziness, light-headedness or unsteadiness. 
 
 
144 Orthostatic BP Analysis 
 
 
145 We applied the following data pre-processing steps to BP data using custom written 
 
146 software (MATLAB® v13.0, The MathWorks Inc., Natick, MA, 2000): a) artefact rejection; b) 
 
147 10-second moving average filtering; and c) feature extraction, as described in detail 
 
148 previously (18). 
 
 
149 Definitions of predictor variables 
 
 
150 Supine SBP, DBP and HR were derived from the average of values occurring 30-60 seconds 
 
151 prior to standing. BP behaviour was characterised by (i) initial transient drop, and (ii) the 
 
152 recovery phase at fixed times after stand as per (11). Initial orthostatic hypotension (IOH) 
 
153 was defined as an initial drop in SBP≥40mmHg and/or drop in DBP≥20mmHg occurring 
 
154 within 15 seconds of standing (with or without symptoms)19. Note beat-to-beat data was 
 
155 used to identify the minimum BP values. Impaired orthostatic BP stabilisation, denoted here 
 
156 as OH(t), was defined (11) by failure to return to within SBP≥20mmHg and/or DBP 
 
157 ≥10mmHg of supine levels at 40s after standing. OH was defined as sustained failure of SBP 
 
158 or DBP to stabilise to within 20mmHg SBP or 10mmHg DBP of supine levels throughout the 
 
159 active stand (11). The selection of these thresholds was based on current clinical guidelines 
 
160 and recent population normative data indicating that these values represent the    5th 
 
161 percentile of orthostatic BP responses in the over 50’s population (11). 
 
 
162 Covariates 
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163 Confounding factors selected on the basis of known interactions with falls or CV risk were 
 
164 recorded at wave 1: age, gender, self-reported educational attainment (primary, secondary 
 
165 or tertiary), living alone, health insurance, self-reported doctor’s diagnosis of common 
 
166 health conditions (HTN, angina, heart attack, heart failure, diabetes, stroke, transient 
 
167 ischaemic attack (TIA), irregular heart rhythm, heart murmur, high cholesterol, cataracts, 
 
168 glaucoma, age-related macular degeneration (ARMD), cancer, arthritis, osteoporosis, or 
 
169 fractures). Medication use was coded using the Anatomical Therapeutic Chemical (ATC) 
 
170 Classification codes for the following medication classes: (a) beta-blockers (ATC code C07), 
 
171 (b) calcium channel blockers (C08), (c) diuretics (C03), (d) angiotensin-converting enzyme 
 
172 inhibitors (C09) (e) angiotensin II receptor antagonists (C09), (f) psychotropics including 
 
173 benzodiazepines (N05B or N05C), antipsychotics (N05A), psychostimulants (N06B), 
 
174 psycholeptics (N06C), anti-depressants (N06A), (g) alpha-blockers (C02CA, C02LE). Mean 
 
175 usual gait speed (cm/sec), mean grip strength (both hands) (kg), cognitive function 
 
176 (Montreal Cognitive Assessment (MOCA) and Mini-mental state examination (MMSE)), 
 
177 mental health (20-item Centre for Epidemiological Studies Depression (CES-D)) scale were 
 
178 also collected. Further study details are published elsewhere (15, 16, 17). Two resting 
 
179 (seated) SBP and DBP measurements were obtained, separated by 1 minute, using an 
 
180 automatic digital oscillometric BP monitor (Model M10-IT, OMRON, Kyoto, Japan). The 
 
181 mean of both SBP and DBP were calculated. Individuals were classified as having 
 
182 hypertension (HTN) if SBP≥140mmHg and/or DBP≥80mmHg (20). 
 
 
183 Statistical Analysis 
 
 
184 Statistical analysis was performed using Stata version 12 (StataCorp. 2011. Stata Statistical 
 
185 Software: Release 12. College Station, TX: StataCorp LP). 
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186 For descriptive analysis, the ‘number of falls’ outcome variable was divided into 3 groups 
 
187 (for ease of tabulation): 0 falls; 1 fall; ≥2 falls while for multivariate analysis, this was coded 
 
188 as 0, 1, 2, 3, 4, or ‘5 or more falls’. Separate binary variables were constructed for UF, IF and 
 
189 syncope. Wave 1 baseline characteristics of those who reported 0, 1, and 2 or more falls 
 
190 during follow up period were compared using ANOVA, Krushkall-Wallis, or Chi-squared test 
 
191 statistics for continuous (normal and non-normal) and categorical variables respectively. 
 
 
192 Prevalence of IOH, OH(40), and OH were reported by age category. Weights were applied 
 
193 to these prevalence estimates to ensure applicability to the whole population (15). Kappa (Κ) 
 
194 statistics assessed the level of agreement between definitions of OH. Chi-squared test 
 
195 statistics were used to assess the association between each of the OH variables considered 
 
196 (IOH, OH(40), and OH) and each outcome variable. 
 
 
197 Separate multiple regression analyses were used to estimate the effect of each OH variant 
 
198 on each outcome, controlling for baseline confounding factors. Negative binomial regression 
 
199 was applied to estimate the effect of OH and its variants on the incidence rate of falls. 
 
200 Modified Poisson regression was used to calculate the effect of OH variants on the risk of IF, 
 
201 UF and syncope (21). Regression models were estimated for each outcome variable 
 
202 adjusting for socio-demographic variables (age, sex, education), and all health-related 
 
203 covariates (See Figure 1). The number of days between interviews was included as an 
 
204 exposure variable to account for the fact that participants with more time between 
 
205 assessments had longer to accrue falls. 
 
 
206 To estimate the moderating effects of age, gender, orthostatic symptoms and HTN on these 
 
207 associations, a stratified analysis was performed. The fully adjusted model was re-estimated 
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208 having stratified the whole population by each of these factors individually. Significance at 
 
209 p<0.05 was assumed. 
 
 
210 RESULTS 
 
 
211 Sample 
 
 
212 4475 participants completed an active stand at wave 1, and 4167 (93%) of these had 
 
213 complete data on incident falls outcomes at wave 2. After applying the exclusion criteria, 
 
214 4127 participants remained for analyses. The mean (SD) time between waves was 743(83.9) 
 
215 days ≈ 24(3) months. 
 
 
216 Participant  characteristics 
 
 
217 The mean (SD) age at wave 1 was 61.5(8.2) years and 54.2% were female. Participants had a 
 
218 mean (SD) MOCA score of 25.4(3.1). Overall 902(21.9%) participants reported one or more 
 
219 falls during follow-up, a total of 1532 falls; 174(4.2%) reported an UF, 369(8.9%) IF, and 
 
220 196(4.8%) syncope (Table 1). There was a marked age related increase in all events – 
 
221 comparing 50 to 59 year olds to participants 80 and older: falls increased from 17.8 to 39.0%; 
 
222 UF from 3.2 to 8.7%; IF from 7.2 to 18.1%; syncope from 3.7 to 9.5% (Table 1). 
 
 
223 [Insert Table 1] 
 
 
224 Fallers were older, and more likely to be female and living alone and reported a higher 
 
225 prevalence of chronic eye conditions, previous hip or wrist fractures, poorer baseline 
 
226 physical and mental health (Table 2). 
 
 
227 [Insert Table 2] 
 
 
228 Prevalence of OH Variants, their Agreement and Age Dependence 
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229 The prevalence of OH variants ranges from 6.9%(95% CI:5.9-7.8) for OH to 32.9%(95% CI: 
 
230 31.2-34.6) for IOH as reported in (11). 
 
 
231 The level of agreement between IOH and both OH(40) (Κ = 0.007) and OH (Κ = 0.011) was 
 
232 low, while a higher but still moderate level of agreement was detected between OH(40) and 
 
233 OH (Κ = 0.481) (See Table A1.1). 
 
 
234 The prevalence of all OH variants, with the exception of IOH increase with age (11). For 
 
235 example, OH(40) is present in 9.2%(95% CI:7.8-10.7) of those aged 50-64 compared to 
 
236 37.2%(95% CI: 25.7-48.7) of those aged over 80 years. 
 
 
237 Characteristics of those with Orthostatic Hypotension and its Variants 
 
 
238 Table 3 details characteristics of individuals with or without OH (and its variants). Those with 
 
239 IOH are younger, have higher levels of education, have better physical health (higher gait 
 
240 speed), and are taking less medication but have marginally higher levels of anxiety and 
 
241 depressive symptoms. On the other hand, those with OH(40), and OH are older, more likely 
 
242 female, have lower levels of education, higher levels of chronic health conditions and 
 
243 medication use. 
 
 
244 [Insert Table 3] 
 
 
245 Prospective Associations between Falls, Syncope and Variants of Orthostatic Hypotension 
 
 
246 At a univariate level, the prevalence of all-cause falls (p<0.001), UF(p=0.007), IF(p<0.001) 
 
247 increased significantly in those with OH(40). Similar patterns existed for OH, with OH (p = 
 
248 0.015) also associated with increased prevalence of syncope. IOH was not associated with 
 
249 any falls outcome considered (Table 4). 
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250 [Insert Table 4] 
 
 
251 Fully adjusted models reveal that OH was associated with the highest risk of all-cause falls 
 
252 (IRR:1.4 95%CI:1.01–1.96; p=0.044), UF(RR:1.81 95%CI:1.06–3.09; p=0.029), and IF(RR:1.58 
 
253 95%CI:1.12–2.24; p=0.010). Similar trends were also noted for OH(40). No associations with 
 
254 IOH or syncope were evident (Figure 1). 
 
 
255 Additional sensitivity analysis suggests these multivariate models are quite robust to the 
 
256 selection of model covariates (although there was some variation in significance across 
 
257 models), with our fully adjusted model reflecting a conservative estimate of the effects 
 
258 between these variables and the outcomes of interest. 
 
 
259 Stratification analysis suggests that in those with HTN, OH(40) is a significant risk factor for 
 
260 each falls outcome considered with similar patterns for OH. Similarly the presence of OH in 
 
261 women was associated with an increased relative risk of all-cause falls, UF, IF. The results 
 
262 associated with age and orthostatic symptoms were less consistent (Table A1.2). 
 
 
263 DISCUSSION 
 
 
264 Our results suggest that impaired orthostatic BP recovery characterised by incomplete or 
 
265 delayed stabilisation is associated with an increased relative risk of future all-cause falls, UF, 
 
266 and IF while IOH is not associated with any of these outcomes. 
 
 
267 This is the first cohort study to report associations between beat-to-beat phasic BP 
 
268 measures, falls and syncope risk. Although there are no prior studies of this nature using 
 
269 phasic BP, our results are consistent with a number of studies (based on standard 
 
270 sphygmomanometer measurements) that indicate that OH is associated with an increased 
 
271 risk of all-cause falls (13, 14). Heitterachi et al., (22) using head-up tilt testing, detected a 
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272 relative risk of 1.7 for OH in fallers versus non-fallers in a small convenience sample (n=70) 
 
273 of older adults. Other longitudinal studies using the sit-to-stand test report no association 
 
274 between falls and OH (23). We would suggest that our large sample size, combined with a 
 
275 more strenuous postural supine-stand challenge and more sensitive phasic BP measurement 
 
276 methods contributed to detection of this positive relationship. 
 
 
277 It appears that the prevalence of OH variants does not follow a uniform distribution in the 
 
278 population, and intermittent measurements (such as those with a standard 
 
279 sphygmomanometer) may underestimate the true prevalence and significance of impaired 
 
280 orthostatic BP behaviour. OH as measured using beat-to-beat approaches were associated 
 
281 with higher absolute risks of falls, UF, IF compared to single point measurements. OH(40) 
 
282 has shown consistent associations with known correlates of falls i.e. increases in mortality 
 
283 (24), impaired cognition (25), and frailty (26,27) which further supports our assertion of the 
 
284 importance of beat-to-beat biomarkers. 
 
 
285 This is also the first cohort study to consider the role of UF. In this sample we report a 
 
286 stronger association between variants of OH and UF than all-cause falls. This may explain 
 
287 the conflicting results of previous studies with the prevalence of UF varying from study to 
 
288 study. UF are often associated with CV events (28) and may be associated with orthostatic 
 
289 BP impairments either because an individual has amnesia for loss of consciousness coupled 
 
290 with unwitnessed syncopal events or because covert cerebral hypoperfusion causes balance 
 
291 instability and resultant falls (13). Repeated subclinical bouts of hypoperfusion in localised 
 
292 centres governing gait and balance, could lead to neurodegenerative changes and ultimately, 
 
293 impaired gait, balance, and UF (28). Additional comorbidities may compound this risk and 
 
294 the likelihood of amnesia for loss of consciousness (30, 31). Finally impaired BP stabilisation 
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295 and falls have been associated with frailty in older adults (26, 27). Our results are however 
 
296 independent of many frailty criteria (gait speed, grip strength), and a wide range of co- 
 
297 morbidities. 
 
 
298 The result that IOH is of limited use in falls risk stratification in older adults warrants further 
 
299 discussion. We suggest the following explanation. Firstly IOH i.e. large BP drops within 15 
 
300 seconds of standing has a very high prevalence in our sample (over 30%). Secondly it’s 
 
301 prevalence does not increase with age. Such a high prevalence and lack of association with 
 
302 age effects the ability of IOH to predict adverse outcomes. Secondly, the cut-off time used in 
 
303 the IOH definition selects individuals with nadirs occurring within 15 seconds of standing. 
 
304 These individual tend have a quicker orthostatic BP recovery profile since they are younger, 
 
305 healthier individuals, that stand more quickly during testing (See Table 3). IOH is therefore 
 
306 not associated with poorer clinical sequelae. Conversely OH(40), which was not correlated 
 
307 with IOH, captures individuals with slower initial drops and a slower recovery and is 
 
308 associated with poorer outcomes. It is likely that these individuals are similar to the frailer 
 
309 older adults attending a post-fall clinical assessment. IOH does not capture these. Finally, 
 
310 our definition of IOH does not include since reporting of symptoms can be unreliable 
 
311 especially in older adults. In light of these observations, an alternative to the current IOH 
 
312 definition maybe sought for use in older community dwelling cohorts to reflect age-related 
 
313 variations in the morphology and timing of the complex BP waveform, patterns of cerebral 
 
314 perfusion and symptom expression. OH(40) maybe a suitable alternative. 
 
 
315 Miller et al. (12) recently noted the clinical dilemma faced regarding management of OH and 
 
316 its variants in the face of coexisting hypertension. Our stratified analysis suggests that 
 
317 coexisting OH(40) and HTN is a risk factor for all-cause falls, UF and IF and is particularly 
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318 important given that over 50% of the over 70's have OH and HTN in this sample. These 
 
319 results may also support previous findings reported by Gangavati et al.(13), the ACCORD (32) 
 
320 and SANDs trials (33) indicating that lower BP (<140/80) does not necessarily increase falls 
 
321 risk. The recent SPRINT study (34) suggests that aggressive treatment of hypertension below 
 
322 120/80mmHg decreases rates of major cardiovascular events, death, and OH, while 
 
323 increasing rates of hypotension, syncope with the rate of injurious falls not changing. 
 
 
324 From the full analysis OH is clearly associated with increased falls risk. However stratification 
 
325 analysis did not lead to a consistent conclusion regarding the role of symptoms. OH tends to 
 
326 be present in older groups often with neurodegenerative disorders and is therefore more 
 
327 likely linked to falls, UF and amnesia for loss of consciousness (30, 31). Self-reported 
 
328 postural symptoms maybe an unreliable marker of cerebral hypoperfusion (35, 36, 37) and 
 
329 therefore restricting testing to older adults with overt postural symptoms may miss those 
 
330 with silent cerebral hypoperfusion and increased falls risk. 
 
 
331 This study has a number of clinical implications especially in the context of assessing falls 
 
332 risk in older adults. Here we identify a novel beat-to-beat risk factors i.e. delayed and/or 
 
333 incomplete BP recovery for injurious and unexplained falls risk. We also note the current 
 
334 definition of IOH is limited in falls risk stratification in community dwelling older adults with 
 
335 refinements warranted in fallers and non-fallers. Furthermore this study highlights the 
 
336 clinical perils of measuring OH in the context of falls where adherence to strict 
 
337 measurement protocol is imperative, with errors easily made that can lead to patient 
 
338 mismanagement. The use of beat-to-beat BP measurement approaches present the clinician 
 
339 with a tool to clearly differentiate between IOH and other important variants of OH, 
 
340 avoiding such issues. Once a subtype of OH is clearly identified these risk factors can be 
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341 managed as per international falls and syncope guidelines. The next step in respect of 
 
342 clinical practice is to ascertain in future intervention trials whether inclusion of these phasic 
 
343 BP measures in clinical practice and targeted intervention for same will reduce subsequent 
 
344 events. 
 
 
345 A number of study limitations must be noted. A regular falls diary was not collected and 
 
346 therefore our falls data relies on the recollection capacity of frailer older adults. However to 
 
347 maximise reliability of our self-reported information, we excluded participants with 
 
348 moderate cognitive impairment and controlled for well-accepted falls risk factors. Given the 
 
349 repeated-measure nature of the BP measurements, multiple statistical tests (n=16 in main 
 
350 effects model) were performed. However, it is unlikely that our results are a chance finding 
 
351 given that 7/16 tests were positive in the main-effects model. The sample considered here is 
 
352 relatively young and healthy and is representative of the over 50’s community dwelling 
 
353 population. It does however under-represent older frail individuals, although our sample 
 
354 does capture a similar proportion of fallers and injurious falls to that which occurs in the 
 
355 total population. In addition, the age stratification analysis presented in the appendix 
 
356 suggests that the effects detected in the whole sample are still present (albeit without 
 
357 statistical significance) in the older sample. The selection of the 20mmHg/10mmHg 
 
358 threshold for defining OH (and variants) although based on population normative data and 
 
359 clinical guidelines may still not be optimum as it is dependent on baseline BP, and age as we 
 
360 have shown previously (11). Assigning a single threshold value to describe such a complex 
 
361 waveform morphology is also a likely limited analytical approach. In addition, the duration 
 
362 of stand was limited to two minutes. It is therefore likely that we have underestimated the 
 
363 effects of delayed OH on falls risk. Exploration of how falls risk varies with waveform 
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364 morphology and key factors that drive differences in these waveforms (e.g. duration of 
 
365 stand, age, gender, resting BP) would be key future considerations in this area. 
 
 
366 In addition to the use of UF and beat-to-beat BP data, this study has a number of significant 
 
367 strengths. Use of the Finometer for measuring changes in BP has been shown to be accurate 
 
368 in a number of studies, although the accuracy of its absolute values has been questioned (37, 
 
369 38). To overcome this, we used baseline measurements from a validated oscillometric 
 
370 device to identify HTN and used changes in beat-to-beat BP only. All measures were 
 
371 collected using internationally standardised protocols and processing of active stand data 
 
372 was objectively performed. 
 
 
373 CONCLUSION 
 
 
374 With the exception of initial orthostatic hypotension, beat-to-beat measures of impaired 
 
375 orthostatic BP recovery (delayed or incomplete stabilisation) are independent risk factors 
 
376 for future falls, unexplained falls, and injurious falls. 
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Table 1: Prevalence of all-cause falls, unexplained falls, injurious falls and syncope stratified by age (n=4127) 
 
  
 
50-59 
 
 
60-69 
Age, years 
 
70-79 
 
 
80+ 
 
 
Total 
Outcomes % (N) % (N) % (N) % (N) % (N) 
Number of participants by age band 46.4 (1,916) 35.5 (1,463) 15.6 (643) 2.5 (105) 100 (4,127) 
All-cause falls*** 17.8 (340) 23.9 (349) 26.7 (172) 39.0 (41) 21.9 (902) 
Unexplained Falls (UF)** 3.2 (61) 4.7 (69) 5.5 (35) 8.7 (9) 4.2 (174) 
Injurious Falls (IF) *** 7.2 (137) 9.3 (136) 12.0 (77) 18.1 (19) 8.9 (369) 
Syncope *** 3.7 (71) 4.7 (69) 7.2 (46) 9.5 (10) 4.8 (196) 
 
539 Table 1. Prevalence of all-cause falls (≥1 fall), unexplained falls, injurious falls and syncope stratified by age 
 
540 occurring between Wave1 and Wave 2 in longitudinal sample (N=4127). Stars indicate a significant difference 
 
541 across age groups, * = P<0.05; ** = P<0.01 *** = P<0.001. 
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Table 2: Cohort characteristics stratified by the number of falls reported at wave 2 (n=4122) 
Number of Falls Reported between Baseline (Wave 1) and Follow-Up 
(Wave 2) 
 
 No Falls  One Fall  Two or More 
Falls 
 
Mean(SD) or 
% 
N Mean(SD) or 
% 
N Mean(SD) or % N 
Age (years) *** 61.1(8.1) 3,225 63.0(8.3) 559 63.4(8.7) 338 
Gender (Female) *** 52.7 1,700 62.8 351 53.8 182 
Education (Primary/none only) 19.9 643 19.5 109 23.4 79 
Living alone *** 15.5 500 22.4 125 17.5 59 
Any Cardiovascular Conditions (1 or 
more) 
Any Chronic Eye Conditions (1 or more) 
60.5 
 
9.7 
1,951 
 
314 
63.5 
 
14.2 
355 
 
79 
64.8 
 
14.3 
219 
 
48 
*** 
Osteoporosis *** 
 
8.8 
 
285 
 
12.3 
 
69 
 
14.8 
 
50 
Hip or wrist fracture *** 10.2 322 13.9 76 18.7 62 
History of Falls *** 14.8 476 30.2 169 44.4 150 
History of Syncope *** 3.6 115 6.3 35 9.2 31 
Health Measures       
MOCA 25.5(3.1) 3,218 25.5(3.1) 557 25.1(3.2) 337 
MMSE 28.7 (1.6) 3224 28.7(1.5) 559 28.6(1.5) 338 
HADS-A*** 5.3(3.5) 2,958 5.6(3.6) 515 6.2(3.7) 293 
CESD *** 4.2(3.8) 3,222 4.5(4.1) 558 5.6(4.5) 336 
Gait Speed (cm/sec) *** 137.8(19.3) 3,197 135(19.2) 554 127.8(24.2) 332 
Grip Strength (kg) *** 26.6(9.5) 3,180 24.6(9.2) 541 24.8(9.7) 329 
Seated Blood Pressure (mmHg) 135.5(22.1) 3,225 138.9(22.4) 559 136.9(23.2) 338 
Medication Use       
Antihypertensives ** 31.4 1013 33.6 188 39.6 134 
Anti-depressants *** 4.6 147 7.5 42 12.7 43 
Polypharmacy *** 15.3 491 17.5 98 30.7 103 
 
550 Table 2. Participant characteristics reported at wave 1 stratified by the number of falls reported at wave 2 
 
551 (n=4122). Hip or wrist fracture = ever fractured a hip or wrist; History of Falls = 1 or more falls in the year 
 
552 (prior to wave 1 interview); History of Syncope = 1 or more faints in the last year (prior to wave 1 interview); 
 
553 MOCA = Montreal Cognitive Assessment; MMSE = Mini-Mental State Exam; HADS-A = Hospital Anxiety and 
 
554 Depression Scale – Anxiety subscale, CESD = Centre of Epidemiological Studies Depression Scale; 
 
555 Cardiovascular Conditions = Presence of 1 or more of the following cardiovascular conditions: Hypertension, 
 
556 Angina, Heart Attack, Heart Failure, Diabetes, High Cholesterol, Heart Murmur, Transient Ischemic Attack, 
 
557 Stroke. Chronic Eye Conditions = Presence of 1 or more of the following eye conditions: Age-related Macular 
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558 Degeneration, Cataracts, Glaucoma. Bold and stars indicate a significant difference between fallers and non- 
 
559 fallers; * = P<0.05; ** = P<0.01 *** = P<0.001. 
 
 
560 
 
 
561 
 
 
562 
 
 
563 
 
 
564 
 
 
565 
 
 
566 
  
 
 
 
 
 
 
 
 
 
 
 
Table 3: Sample characteristics stratified by those individuals with or without OH and its variants. 
 IO
H 
OH(40
) 
O
H 
 No 
Mean(SD) 
 
 
N 
Yes 
Mean(SD) 
 
 
N 
No 
Mean(SD) 
 
 
N 
Yes 
Mean(SD) 
 
 
N 
No 
Mean 
 
 
N 
Yes 
Mea
n 
 
 
N 
Age (years) 62.3(8.3) 2704 60.0(7.9) 1408*** 60.9(7.9) 3,577 65.5(9.3) 550*** 61.3(8.1) 3,893 65.2(9.2) 221*** 
Gender (Female) 55.2 1491 52.5 739 53.5 1,915 58.4 321* 53.4 2,083 67.0 148*** 
Education (Primary/none 21.7 588 17.0 240*** 19.0 681 28.0 154*** 19.8 772 27.6 61* 
only)             
Living alone 17.2 464 15.3 215*** 15.5 555 23.5 129*** 16.2 631 23.5 52*** 
Any Cardiovascular 63.1 1707 57.6 811** 60.5 2,163 66.4 365** 61.2 2,387 62.0 137 
Conditions (1 or more)             
Any Chronic Eye Conditions 11.6 313 9.0 126* 9.8 348 17.3 95*** 10.4 404 16.7 37** 
(1 or more)             
Osteoporosis 10.2 276 9.0 127 9.4 337 12.2 67* 9.4 368 15.4 34** 
Hip or wrist fracture 12.3 326 9.8 135* 11.0 386 13.8 75 11.3 432 12.4 27 
History of Falls 19.4 525 19.2 270 18.6 665 24.5 135*** 19.0 742 24.9 55* 
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Table 3. Sample characteristics stratified by those individuals with or without OH and its variants. Hip or wrist fracture = ever fractured a hip or wrist; History of Falls = 1 or 
more falls in the year (prior to wave 1 interview); History of Syncope = 1 or more faints in the last year (prior to wave 1 interview); MOCA = Montreal Cognitive Assessment; 
MMSE = Mini-Mental State Exam; HADS-A = Hospital Anxiety and Depression Scale - Anxiety subscale, CESD = Centre of Epidemiological Studies Depression Scale; 
History of Syncope 4.6 124 4.1 58 4.3 155 5.1 28 4.3 169 6.4 14 
Health Measures             
MOCA 25.3(3.2) 2699 25.6(3.0) 1404** 25.5(3.1) 3,569 25.1(3.2) 549** 25.4(3.1) 3,8990 25.5(3.0) 221 
MMSE 28.6(1.7) 2703 28.9(1.4) 1408*** 28.8(1.6) 3,576 28.5(1.7) 550*** 28.7(1.6) 3,898 28.7(1.5) 221 
HADS 5.3(3.5) 2461 5.6(3.6) 1296** 5.4(3.5) 3,278 5.2(3.7) 491 5.4(3.5) 3,566 5.3(3.3) 199 
CESD 4.4(4.0) 2701 4.3(3.9) 1405 4.3(3.9) 3,572 4.6(4.0) 550* 4.3(3.9) 3,894 4.6(4.1) 220 
Gait Speed 135.3(20.4) 2675 139.2(18.7) 1398*** 137.6(19.6) 3,551 130.4(20.9) 537*** 136.9(19.8) 3,861 130.8(21.2) 220*** 
(cm/sec)             
Grip Strength (kg) 26.0(9.6) 2652 26.7(9.4) 1388* 26.6(9.6) 3,517 24.0(8.9) 538*** 26.4(9.5) 3,830 23.2(8.6) 218*** 
Supine Blood 136.1(22.6) 2704 136.1(21.3) 1408 135.1(21.5) 3,577 143.5(25.1) 550*** 135.5(21.8) 3,899 146.6(26.1) 221*** 
Pressure (mmHg)             
Medication Use             
Antihypertensives 35.4 957 26.5 373*** 31.1 1,112 40.9 225*** 32.1 1,252 37.1 82 
Anti-depressants 5.4 147 6.0 85 5.0 180 9.6 53*** 5.5 213 9.0 20* 
Polypharmacy 18.8 507 13.0 183*** 15.5 554 25.7 140*** 16.5 642 22.4 49* 
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Cardiovascular Conditions = Presence of 1 or more of the following cardiovascular conditions: Hypertension, Angina, Heart Attack, Heart Failure, Diabetes, High Cholesterol, 
Heart Murmur, Transient Ischemic Attack, Stroke. Chronic Eye Conditions = Presence of 1 or more of the following eye conditions: Age-related Macular Degeneration, 
Cataracts, Glaucoma. IOH = initial orthostatic hypotension; OH(40) = impaired blood pressure stabilisation at 40 seconds after standing; after standing. Cut-off values used 
for OH(40), and  OH are drops of 20mmHg SBP and/or 10mmHg DBP, while IOH is based on a drop of 40mmHg SBP and/or 20mmHg DBP. Bold and stars indicate a 
significant difference between OH and non-OH groups; * = P<0.05; ** = P<0.01 *** = P<0.001. 
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Table 4: Proportion of participants experiencing falls and syncope by variants of orthostatic 
hypotension. 
 Wave 2 
OH Variant Falls 
Unexplained 
Falls 
Injurious 
Falls 
 
Syncope 
1 Fall 2+ Falls 
IOH No %(N) 
Yes %(N) 
13.9 (376) 8.3 (223) 
 
12.8 (180) 8.2 (115) 
 
12.8 (459) 7.9 (282) 
 
18.2 (100) 10.2 (56)*** 
 
13.4 (523) 8.0 (313) 
 
15.8 (35) 11.3 (25) 
4.6 (124) 
 
3.6 (50) 
 
3.9 (139) 
 
6.4 (35)** 
 
4.0 (157) 
 
7.7 (17)** 
9.3 (252) 
 
8.2 (116) 
 
8.3 (297) 
 
13.1 (72)*** 
 
8.6 (334) 
 
15.4 (34)*** 
5.4 (146) 
 
3.5 (49)** 
 
4.5 (162) 
 
6.2 (34) 
 
4.6 (178) 
 
8.1 (18)* 
OH(40) No %(N) 
Yes %(N) 
OH No %(N) 
Yes %(N) 
Table 4. Proportion of participants experiencing falls and syncope by variants of orthostatic hypotension. Univariate associations between number of falls, unexplained 
falls (UF), injurious falls (IF), and syncope at wave 2 and variants of orthostatic hypotension. Results for IOH, OH(40), OH are shown. Significance and p value indicates an 
association between categorical variables tested using a Chi squared test. IOH = initial orthostatic hypotension; OH(40) = impaired blood pressure stabilisation at 40 
seconds after standing; OH = orthostatic hypotension. Cut-off values used for OH(40), and OH are defined by drops of 20mmHg SBP and/or 10mmHg DBP, while IOH is 
based on a drop of 40mmHg SBP and/or 20mmHg DBP within 15 seconds of standing. 
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Figure 1: Multivariate models examining the relationship between variants of OH and syncope and falls. 
 IRR/RR (95% CI) P 
All-Cause Falls 
IOH 
 
1.10 (0.93-1.31) 
 
0.250 
OH(40) 1.23 (0.98-1.55) 0.074 
OH 1.40 (1.01-1.96) .044* 
Unexplained falls   
IOH 0.92 (0.65-1.32) 0.657 
OH(40) 1.52 (1.03-2.26) 0.039* 
OH 1.81 (1.06-3.09) 0.029* 
Injurious Falls   
IOH 0.94 (0.75-1.18) 0.582 
OH(40) 1.29 (0.98-1.7) 0.068 
OH 
Syncope 
IOH 
1.58 (1.12-2.24) 
 
0.75 (0.53-1.06) 
0.010** 
 
0.101 
OH(40) 0.94 (0.63-1.41) 0.774 
OH 1.20 (0.70-2.06) 0.505 
 
 
 
 
Figure 1. Multivariate models examining the relationship between variants of OH and syncope and falls. UF = Unexplained falls; IOH = initial orthostatic hypotension; OH(40) =impaired blood 
 
pressure stabilisation at 40 seconds after standing; OH = . Bold = P<0.05. Cut-off values used for OH(40), and OH are drops of 20mmHg SBP or 10mmHg DBP. IOH is based on a drop of 
40mmHg SBP and/or 20mmHg DBP within 15 seconds of standing. Models are adjusted for Age, Gender, Education, Time between interviews, Living alone, Angina, Heart Attack, Heart Failure, 
Diabetes, Trans Ischemic Attack, High Cholesterol, Heart Murmur, Stroke, Health Insurance, Orthostatic Intolerance, Baseline SBP, Baseline HR, Cataracts, Glaucoma, ARMD, Cancer, Arthritis, 
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Irregular rhythm, Gait speed, BMI, Grip Strength, Disability, Osteoporosis, Fractures, MOCA score, HADSA score, CESD score, Alpha blockers, Beta blockers, Calcium channel blockers, 
Diuretics, ACE Inhibitors, Angiotensin-Renin Blockers, Antidepressants. 
